News & Updates
Filter by Specialty:
Nivolumab-chemo poised to alter NSCLC treatment landscape
In the 3-year analysis of the phase III CheckMate 816 trial, neoadjuvant nivolumab plus platinum doublet chemotherapy (nivo-chemo) continued to provide durable benefit for individuals with resectable non-small-cell lung cancer (NSCLC).
Nivolumab-chemo poised to alter NSCLC treatment landscape
06 Jun 2023
Fruit and vegetable intake lowers endometrial cancer risk
Eating fruits and vegetables may help reduce the risk of endometrial cancer, suggests a recent study, noting that specific kinds of fruits and vegetables must be recommended based on their outstanding bioactive components.
Fruit and vegetable intake lowers endometrial cancer risk
02 Jun 2023
Functional surgery delivers amputation-free benefit in nail unit melanoma
Patients who have nail unit melanoma (NUM) with a Breslow thickness (BT) of <0.8 mm may benefit from functional surgery, which offers an amputation-sparing advantage, suggests a recent study.
Functional surgery delivers amputation-free benefit in nail unit melanoma
29 May 2023
HCT treatment tied to lower cancer risk, except skin cancer
Treatment with hydrochlorothiazide (HCT) contributes to a lower all-cancer risk and a slightly higher skin cancer risk compared with alternative diuretics, reports a study involving a German population.